<DOC>
	<DOC>NCT01826435</DOC>
	<brief_summary>The study team is proposing a single arm intervention to test the effect of an electronic intervention on medication use among individuals with a prescription for hypertension/high blood pressure. The investigator proposes that technology like text messaging, email, web applications and mobile apps with proven, nurse intervention scripts, will lead to significant, cost-effective improvements in hypertension medication use.</brief_summary>
	<brief_title>Improving Medication Adherence in Hypertensive Patients</brief_title>
	<detailed_description>The intervention will incorporate a scalable electronic intervention using Email/Web Apps and Short Message Service (SMS)/Mobile Web Apps. The study team will examine the participants' responses to the electronic encounters in the technology-only intervention throughout the 3-month study timeframe.</detailed_description>
	<criteria>Enrolled in the primary care clinic for the past 6 months New or existing prescription for hypertension Poorly controlled mean systolic blood pressure (SBP) in the last 12 months (&gt;140/90 Hg) Hospitalized for a stroke, myocardial infarction, coronary artery revascularization in the past 3 months, Diagnosis of metastatic cancer; Active diagnosis of psychosis or dementia documented in medical record; Does not have access to the appropriate technology required Is not willing to use said device to receive notifications for the study; Does not live independently (assisted living or nursing home residents) or otherwise institutionalized or receiving home health care Severely impaired hearing, vision or speech (unless technological aides allow them full functionality) Planning to leave the area or change primary care clinics prior to the anticipated end of participation; Unable to read and understand spoken English Participation in another cardiovascular disease (CVD) study Another household member enrolled in study; Arm size &gt; 50cm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>